Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Alcoholism, Clinical and Experimental Research|March 3, 2007
Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: comparison with liver cirrhosis CHideaki Takahashi, Michihiro Suzuki, Hiroki Ikeda, et al.World Journal of Gastroenterology|June 15, 2006
Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis CChiaki Okuse, Hiroshi Yotsuyanagi, Yoshihiko Nagase, et al.Intervirology|February 5, 2003
Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapyNahoko Okamoto, Hiroshi Yotsuyanagi, Seido Ooka, et al.Alcoholism, Clinical and Experimental Research|August 20, 2004
Strategy for hepatic hyperplastic nodules in heavy drinkersMichihiro Suzuki, Shiro Maeyama, Hideaki Takahashi, et al.Human Immunology|December 18, 2004
Identification of a new autoantibody in patients with chronic hepatitisYasunobu Fukuda, Hiroshi Yotsuyanagi, Seido Ooka, et al.Pathology International|January 10, 2006
Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladderHiroki Ikeda, Michihiro Suzuki, Hideaki Takahashi, et al.World Journal of Gastroenterology|March 14, 2007
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case reportYuka Suzuki, Hiroshi Yotsuyanagi, Chiaki Okuse, et al.Human Pathology|February 2, 2002
Esophageal extraskeletal Ewing's sarcomaChihaya Maesawa, Sin Iijima, Nobuhiro Sato, et al.Journal of Gastroenterology|February 9, 2007
A case of deep venous thrombosis associated with pegylated interferon alpha2b plus ribavirin treatment of chronic hepatitis CChiaki Okuse, Kayo Adachi, Yoshiki Katakura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2007
Effect of treatment with interferon alpha-2b and ribavirin in patients infected with genotype 2 hepatitis C virusYoshihiko Nagase, Hiroshi Yotsuyanagi, Chiaki Okuse, et al.Pageof 8